CompanyDeals

Topchoice Medical to Acquire 19% Stake in Heren Health for $72.2M

CompanyDeals

Eluminex Biosciences Closes $40M Series B for Ophthalmic Innovations

CompanyDeals

RinuaGene Raises $14.4M in Pre-Series A+ for mRNA Drug Development

Company

Junshi Biosciences Reports 2022 Preliminary Earnings with Revenue Decline

CompanyDeals

Chipscreen Biosciences Licenses First-in-Class BsAb YH008 from Eucure

CompanyDrug

Novartis’ LNP023 and Janssen’s Tremfya on Track for Breakthrough Designations

CompanyDeals

Suzhou Porton Biologics Partners with CorrGene for Cell and Gene Therapy

CompanyDrug

Sanofi’s Sarclisa Approved for Import in Shenzhen via Greater Bay Area Scheme

CompanyDrug

Innovent Biologics Begins Phase I Trial for IBI333 in Neovascular AMD

CompanyDrug

Hybio’s COVID-19 Nasal Spray HY3000 Gets FDA Clinical Trial Approval

CompanyDrug

Junshi Biosciences’ PCSK9 Inhibitor Ongericimab Meets Phase III Endpoints

CompanyDeals

Oricell Therapeutics Closes $45M Series B1 Round for Cellular Immunotherapy